F, L., D, B., J, R., C, G., M, S., B, C., . . . C, D. (2026). Age-Dependent Cardiovascular Adverse Event Reporting With Pathway-Directed Anticancer Therapies in Children and Adults: A VigiBase Disproportionality Analysis. Pediatric blood & cancer, 73(8), e70413. https://doi.org/10.1002/1545-5017.70413
Chicago Style (17th ed.) CitationF, Labombarda, Bodet D, Rouger J, Guérin C, Sassier M, Chrétien B, Alexandre J, and Dolladille C. "Age-Dependent Cardiovascular Adverse Event Reporting With Pathway-Directed Anticancer Therapies in Children and Adults: A VigiBase Disproportionality Analysis." Pediatric Blood & Cancer 73, no. 8 (2026): e70413. https://doi.org/10.1002/1545-5017.70413.
MLA (9th ed.) CitationF, Labombarda, et al. "Age-Dependent Cardiovascular Adverse Event Reporting With Pathway-Directed Anticancer Therapies in Children and Adults: A VigiBase Disproportionality Analysis." Pediatric Blood & Cancer, vol. 73, no. 8, 2026, p. e70413, https://doi.org/10.1002/1545-5017.70413.